UBS Heightens Expectations for Corteva (CTVA) with an $8 Price Target Raise

Corteva, Inc. (NYSE:CTVA) is one of the 10 High Growth Chemical Stocks to Buy.

UBS Heightens Expectations for Corteva (CTVA) with an $8 Price Target Raise

UBS raised the price target on Corteva, Inc. (NYSE:CTVA) from $80 to $88 and maintained a Neutral rating on the stock on April 9, 2026, signaling confidence in the company’s future growth value.

Prior to this, in a separate event, on March 31, 2026, Argus, an independent investment research firm, raised its price target on Corteva, Inc. (NYSE:CTVA) from $80 to $91. The firm’s analyst, Alexandra Yates, maintained a Buy rating on the company’s stock. The firm cited Corteva, Inc. (NYSE:CTVA)’s strong track record in the industry and a well-performing company. In the research note, the firm further expressed confidence in the company’s ability to continue to build on demand momentum, while its cost-reduction strategies alongside pricing gains will drive the margins upwards.

Based on the CNN data, Corteva, Inc. (NYSE:CTVA) maintains a consensus Buy rating from 28 analysts following the stock. The stock is expected to rise by 7.05% on average over 1 year.

Corteva, Inc. (NYSE:CTVA) is an agriculture technology company, formed in 2018 as a subsidiary of DowDuPont and became an independent public company on June 1, 2019, following its spin-off. Headquartered in Indiana, the company provides seed and crop protection solutions.

While we acknowledge the risk and potential of CTVA as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than CTVA and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: MLP Stocks List: 20 Largest MLPs and 10 Top Stocks Fund Managers Are Loading Up On in 2026.

Disclosure: None.  Follow Insider Monkey on Google News.